Attached files

file filename
EX-31.2 - EXHIBIT 31.2 - SKINOVATION PHARMACEUTICAL INCskin9302013form10qex312.htm
EXCEL - IDEA: XBRL DOCUMENT - SKINOVATION PHARMACEUTICAL INCFinancial_Report.xls
10-Q - FORM 10-Q - SKINOVATION PHARMACEUTICAL INCskin9302013form10q.htm
EX-31.1 - EXHIBIT 31.1 - SKINOVATION PHARMACEUTICAL INCskin9302013form10qex311.htm

Exhibit 32.1

 

 

SKINOVATION PHARMACEUTICAL INCORPORATED

 

CERTIFICATION OF PERIODIC REPORT

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

18 U.S.C. Section 1350

 

The undersigned executive officer of Skinovation Pharmaceutical Incorporated certifies pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:

 

a.the quarterly report on Form 10-Q of Skinovation Pharmaceutical Incorporated for the quarter ended September 30, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

b.the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Skinovation Pharmaceutical Incorporated.

 

   
Date: November 11, 2013  By: /s/ Huge Rodier
   

Hugo Rodier
Principal Executive Officer

Principal Financial Officer